Richard Band

Richard Band

Richard Band is the author of Contrary Investing, in addition to numerous investment monographs. He has appeared on financial radio and TV and has been quoted in The Wall Street Journal, Business Week, Forbes and other leading publications. Richard graduated from Yale University, magna cum laude, and has been a respected investment commentator since 1982.

Recent Articles

Toronto-Dominion Bank (TD) Stock: The Great White North’s Bank of Choice

By Richard Band

TD continues to expand in the U.S., which has helped diversify its revenue stream while also hedging its revenue growth.

The Coca-Cola Co (KO) Stock Is Fizzing With Value

By Richard Band

WIth The Coca-Cola Co (KO) proving its ability to flourish, now is the perfect time to buy some KO stock -- while the Street is still cautious.

Roche Holding Ltd. (RHHBY) Still Has a Few Tricks Up its Sleeve

By Richard Band

The Big Pharma is set to have a very good 2017 and put 2016 behind it.

Why AbbVie Inc (ABBV) Stock Is Still a Long-Term Winner

By Richard Band

The market has been hot and cold on biotechs, but AbbVie stock is a great long-term winner. Here's what you need to know about ABBV.

Think Sanofi SA (ADR) (SNY) Stock When You Think Big Pharma

By Richard Band

Sanofi has a rough time during 2016, but after the U.S. presidential election and with several forward-looking decisions, SNY stock is a buy.

Load More